SYP and Alzheimer disease: AD primarily targets synapses, and synaptic loss and dysfunction have been reported to be well correlated with cognitive dysfunction in AD [1]–[3]Immunoreactivity against synaptophysin, a presynaptic marker protein, is reduced by approximately 25% in the brains of patients with mild AD [4].